Abdoulaye Sene, PhD, is a dedicated neuroscientist and expert in bringing scientific discoveries to real-world medical treatments. With over 15 years of experience, he is currently the Vice President of Translational Science at Kartos Therapeutics, where he leads groundbreaking research projects. Before joining Kartos, Dr. Sene held key positions at major pharmaceutical companies like Genentech and Allergan, contributing to cutting-edge research programs. He also served as a Research Instructor and Postdoctoral Research Associate at Washington University School of Medicine in St. Louis, focusing on improving understanding and treatments for vision disorders. Dr. Sene earned his PhD in Neuroscience from Pierre and Marie Curie University in Paris, France. He has also taught at Université de Cergy-Pontoise, demonstrating a strong commitment to mentoring future scientists and advancing medical research.
His extensive expertise makes him a sought-after advisor and leader for biotechnology and healthcare organizations looking for innovative solutions to complex challenges.
Biography
Abdoulaye Sene, PhD, is a dedicated neuroscientist and expert in bringing scientific discoveries to real-world medical treatments. With over 15 years of experience, he is currently the Vice President of Translational Science at Kartos Therapeutics, where he leads groundbreaking research projects. Before joining Kartos, Dr. Sene held key positions at major pharmaceutical companies like Genentech and Allergan, contributing to cutting-edge research programs. He also served as a Research Instructor and Postdoctoral Research Associate at Washington University School of Medicine in St. Louis, focusing on improving understanding and treatments for vision disorders. Dr. Sene earned his PhD in Neuroscience from Pierre and Marie Curie University in Paris, France. He has also taught at Université de Cergy-Pontoise, demonstrating a strong commitment to mentoring future scientists and advancing medical research.
His extensive expertise makes him a sought-after advisor and leader for biotechnology and healthcare organizations looking for innovative solutions to complex challenges.
Contact Form